Shire Balance Sheet | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Shire PLC

Shire PLC | Balance Sheet

Fiscal year is January-December. All values GBP Millions.

2013

2014

2015

2016

2017

2018

2019

Cash & Short Term Investments

1,365

1,948

150

449

378

375,168

702,093

Total Accounts Receivable

696

751

877

2,342

2,402

428,792

749,119

Inventories

275

349

431

2,883

2,433

212,944

986,744

Other Current Assets

253

276

428

411

61,904

589,426

Total Current Assets

2,589

3,324

1,530

6,102

5,624

1,078,808

3,050,658

Net Property, Plant & Equipment

538

537

562

5,236

4,905

536,801

1,316,531

Total Investments and Advances

155

178

304,385

306,899

Intangible Assets

1,773

4,752

9,038

42,557

39,089

2,043,512

9,021,771

Other Assets

123

152

77,977

87,472

Total Assets

5,025

8,743

11,269

54,251

50,088

4,106,463

13,872,322

ST Debt & Current Portion LT Debt

545

1,026

2,483

2,062

Accounts Payable

122

159

228

738

676

Income Tax Payable

Other Current Liabilities

928

1,224

1,211

3,046

3,041

Total Current Liabilities

1,092

1,938

2,514

6,267

5,827

Long-Term Debt

16,105

12,384

Provision for Risks & Charges

Deferred Taxes

253

705

1,415

6,657

3,370

Other Liabilities

355

472

542

1,717

1,625

Total Liabilities

1,785

3,187

4,601

30,824

23,345

Common Equity (Total)

3,240

5,556

6,669

23,427

26,743

Total Shareholders' Equity

3,240

5,556

6,669

23,427

26,743

Total Equity

3,240

5,556

6,669

23,427

26,743

Liabilities & Shareholders' Equity

5,025

8,743

11,269

54,251

50,088

About Shire

View Profile

Address	4-1-1 Dosho-machi Osaka Osaka 540 Japan
Employees	-
Website	http://www.takeda.co.jp
Updated	07/08/2019
Shire Plc is a biopharmaceutical company. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol.